ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Discovery of Process to Harness Energy Could Affect Synthetic Biology, Fuel, Chemical Production – UKNow (press release)

Continue reading

2017-08-22 Michael Zand NEWS

Winnipeg man to donate stem cells to critically ill stranger in Israel – CBC.ca


UKNow (press release)

Discovery of Process to Harness Energy Could Affect Synthetic Biology, Fuel, Chemical Production
UKNow (press release)
LEXINGTON, Ky. (Aug. 22, 2017) — University of Kentucky researchers participating in a Department of Energy funded center have discovered a groundbreaking process that allows them to harness energy from chemical reactions that previously would have …

Continue reading

2017-08-22 Michael Zand NEWS

Studies highlight ‘potential new targets for immunotherapy’ – Cancer Research UK


CBC.ca

Winnipeg man to donate stem cells to critically ill stranger in Israel
CBC.ca
When Alex Shor heard that he was a match for a stranger in Israel who would likely die without a stem cell transplant, he didn’t think twice before saying “yes.” “If I today I help somebody, tomorrow I want somebody to help me too if I [am] sick,” said …

Continue reading

2017-08-22 Michael Zand NEWS

Stem Cell Cartilage Regeneration Market Consumption (Sales) Comparison by Application to 2022 – Medgadget (blog)

Stem Cell Cartilage Regeneration Market Consumption (Sales) Comparison by Application to 2022Medgadget (blog)Global Stem Cell Cartilage Regeneration Market Research Report 2017 to 2022 presents an in-depth assessment of the Stem Cell Cartilage Regenera… Continue reading

2017-08-22 Michael Zand NEWS

Mechanism Behind Poor Response to Immunotherapy in Some Cancers Identified – Technology Networks

Technology NetworksMechanism Behind Poor Response to Immunotherapy in Some Cancers IdentifiedTechnology NetworksJonathan Serody, MD, Benjamin Vincent, MD, and a team of UNC Lineberger investigators published findings in the Journal of Clinical Investig… Continue reading

2017-08-22 Michael Zand NEWS

Mechanism Behind Poor Response to Immunotherapy in Some Cancers Identified – Technology Networks

Technology NetworksMechanism Behind Poor Response to Immunotherapy in Some Cancers IdentifiedTechnology NetworksJonathan Serody, MD, Benjamin Vincent, MD, and a team of UNC Lineberger investigators published findings in the Journal of Clinical Investig… Continue reading

2017-08-22 Michael Zand NEWS

Mechanism Behind Poor Response to Immunotherapy in Some Cancers Identified – Technology Networks

Technology NetworksMechanism Behind Poor Response to Immunotherapy in Some Cancers IdentifiedTechnology NetworksJonathan Serody, MD, Benjamin Vincent, MD, and a team of UNC Lineberger investigators published findings in the Journal of Clinical Investig… Continue reading

2017-08-22 Michael Zand NEWS

Cancer Gene Therapy Market to Witness an Outstanding Growth by Forecast 2025 – Medgadget (blog)

Cancer Gene Therapy Market to Witness an Outstanding Growth by Forecast 2025Medgadget (blog)Gene therapy is a massive and swiftly expanding field that could hold promising cures and treatments for several diseases and genetic problems. One of the more … Continue reading

2017-08-22 Michael Zand NEWS
  • 1
  • …
  • 1,326
  • 1,327
  • 1,328
  • 1,329
  • 1,330
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Cancer Research UK

Studies highlight ‘potential new targets for immunotherapy‘
Cancer Research UK
Dr Edd James, a Cancer Research UK-funded expert on immunotherapy from the University of Southampton, said: “The findings from this research raise an exciting prospect as they indicate possible new targets for immunotherapy, which may work alone or in …
Mechanism Behind Poor Response to Immunotherapy in Some Cancers IdentifiedTechnology Networks

all 2 news articles »